Advanz Pharma
London
About Advanz Pharma
ADVANZ PHARMA is a global pharmaceutical company focussed on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche established medicines. The Company has an international footprint with sales in more than 100 countries and has a diversified portfolio of more than 200 established, off-patent molecules that make up more than 1,300 SKUs. It also markets orphan drugs through its Orphan Drug Division, currently consisting of Photofrin for the treatment of certain rare forms of cancer, which is currently undergoing testing for potential new indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $1.3B
- Funding stage: M&A
- Last round: Debt Financing (Apr 2025)
- Ticker: nasdaq:CXRX
- Website: advanzpharma.com
- Phone: +46 (0) 42-13 57 70
Industries & Categories
Health Care, Hospital, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/advanz-pharma-81974 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.